Newsletter | November 12, 2024

11.12.24 -- Improving Patient Diversity And The Screening Process

Optimize Your Oncology Trial Protocol With Real-World Data

Set your next oncological clinical trials up for success using high-quality real-world data (RWD) to anticipate and confront potential problems early on. Explore how trial sponsors and CROs can now utilize high-quality RWD-backed protocol design to help assess your trial's feasibility, improve patient representation and eligibility, and more.

 

Broadening Eligibility Criteria Among Cancer Clinical Trials Patients

This study challenges exclusionary approaches to clinical trials that underrepresent certain populations and limit the generalizability of research advancements. Using a nationwide electronic health record-derived de-identified database, this study evaluates the effect of broadened eligibility criteria on sociodemographic diversity.

 

Benefits Of Delegating The Patient Screening Process For Oncology Trials

In the complexity of oncology trials, EHRs have enhanced patient safety and workflow efficiency. Despite these benefits, EHRs can be costly and result in extended timelines. Learn how a hybrid model that leverages specialized health data companies could be a more effective way to streamline the patient screening process.

 

SOLUTIONS

Protocol Optimization And Patient Identification Solutions

This adaptive set of data and tech-enabled services, delivered by oncology and clinical research experts, is designed to help sponsors optimize clinical trial protocols, select ideal trial sites, and identify trial-eligible patients, ensuring research is set up for operational success.

• Request Information

 

 

 

Watch Flatiron Clinical Pipe™ In Action

Learn how you can save time with Flatiron Clinical Pipe™, the leading EHR-to-EDC connector that can transfer structured and unstructured data. Lower your data monitoring costs, accelerate data cleaning timelines, and hit study milestones faster.

• Request Information